| 000 | 01676 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514043105.0 | ||
| 264 | 0 | _c20030610 | |
| 008 | 200306s 0 0 eng d | ||
| 022 | _a1424-8832 | ||
| 024 | 7 |
_a10.1159/000057282 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPaspatis, Gregorios A | |
| 245 | 0 | 0 |
_aResistance to activated protein C, factor V leiden and the prothrombin G20210A variant in patients with colorectal cancer. _h[electronic resource] |
| 260 |
_bPathophysiology of haemostasis and thrombosis _c |
||
| 300 |
_a2-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aActivated Protein C Resistance _xblood |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xblood |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aFactor V _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemostasis _xgenetics |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aPartial Thromboplastin Time |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aProthrombin _xgenetics |
| 700 | 1 | _aSfyridaki, Aikaterini | |
| 700 | 1 | _aPapanikolaou, Nikolaos | |
| 700 | 1 | _aTriantafyllou, Kostantinos | |
| 700 | 1 | _aLivadiotaki, Aikaterini | |
| 700 | 1 | _aKapsoritakis, Andreas | |
| 700 | 1 | _aLydataki, Niki | |
| 773 | 0 |
_tPathophysiology of haemostasis and thrombosis _gvol. 32 _gno. 1 _gp. 2-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000057282 _zAvailable from publisher's website |
| 999 |
_c12094883 _d12094883 |
||